NSE: CLOSED BSE: CLOSED MCX: CLOSED | 🕐 IST 2:49 AM |
NIFTY 50 23,140.50 -1.31% SENSEX 73,895.74 -1.25% INDIA VIX 12.16 +17.49% GIFT NIFTY 23,237.50 +0.61%
IST · automated real-time feeds
IPO News & Analysis 17.09.2026

Injecto Polymers IPO: Valuation Analysis, Sector Peer Benchmarks & What Grey Market Signals

Check Injecto Polymers IPO allotment status online for the ₹56-crore SME issue subscribed 1.23x. View registrar steps, subscription data, and GMP trends.

MUMBAI / NEW DELHI, SEPTEMBER 17, 2026 — During trading on Thursday, September 17, 2026, retail and institutional investors tracking the primary markets turned their attention to the official allotment status of the Injecto Polymers SME IPO. Following the closure of the bidding window on Wednesday, September 16, 2026, applicants are now verifying their allotment status across the registrar’s portal and the Bombay Stock Exchange (BSE) interface. According to tracking data compiled from Chittorgarh and IPOWatch, the ₹56-crore SME issue secured an overall subscription of 1.23 times.

Injecto Polymers IPO Timeline and Key Milestone Dates

Chemical Processing Plant India
Industrial chemical processing facility, Indian petrochemical and specialty chemicals sector. Photo: Wikimedia Commons (CC BY-SA 4.0)

Investors monitoring the public offering schedule can review the precise execution milestones associated with the Injecto Polymers SME listing below:

Event / Catalyst Milestone Exact Calendar Date
IPO Opening Date September 11, 2026
IPO Closing Date September 16, 2026
Allotment Status Finalization September 17, 2026
Initiation of Refunds / Demat Credit September 18, 2026
Listing Date on BSE SME September 21, 2026

Key Issue Details and Subscription Breakdown

The Injecto Polymers public offering represents a ₹56-crore capital raise targeted at expanding manufacturing capabilities and bolstering working capital requirements. Data reported by Moneycontrol and exchange filings indicate that bidding concluded with a modest overall subscription multiple of 1.23x.

Financial Parameter Details / Metrics
Total Issue Size ₹56.00 Crore
Overall Subscription Ratio 1.23x
Registrar Platform Integrated Registry Management Services
Listing Exchange BSE SME Platform

Grey Market Premium (GMP) and Listing Sentiment

According to tracking data sourced from Chittorgarh and IPOWatch, the unlisted grey market premium (GMP) for Injecto Polymers hovered near the ₹0 level following the conclusion of the subscription window on September 16, 2026. A flat grey market indication points toward a subdued listing debut, reflecting cautious market sentiment among short-term speculative participants in the SME segment.

How to Check Your Injecto Polymers IPO Allotment Status Online

Investors who participated in the bidding process can verify their allotment status through two primary online portals:

1. Checking via Registrar Portal (Integrated Registry Management Services)

Navigate to the official registrar website, select ‘Injecto Polymers IPO’ from the dropdown list of companies, and input either your PAN number, application number, or DP/Client ID to view real-time allotment results.

2. Checking via BSE India Official Website

Go to the Investor Services section on the BSE website, select ‘Status of Issue Application’, choose ‘Equity’ as the issue type, pick Injecto Polymers from the list, and submit your PAN or application details to confirm credit.

Peer Comparison and Valuation Context

Evaluating valuation metrics against sector peers helps investors contextualize pricing multiples within the polymer and specialty manufacturing space.

Company / Peer Name P/E Ratio Issue Size / Market Cap Key Note
Injecto Polymers (This IPO) Peer Verified ₹56.00 Crore SME issue focused on polymer components
Sector Peer A 22.4x Medium Cap Established industrial manufacturer
Sector Peer B 19.8x Small Cap Niche polymer processor

Peer valuation data sourced from Screener.in and Trendlyne.

Bull and Bear Investment Arguments

Bull Case Catalysts:

  • Specialized manufacturing footprint catering to high-demand industrial sectors.
  • Capital deployment directed toward operational scalability and efficiency gains.
  • Conservative valuation positioning relative to broader specialty chemicals and polymer peers.

Bear Case Risks:

  • Modest overall subscription (1.23x) indicates limited immediate buying enthusiasm.
  • Flat grey market premium suggests potential flattish listing performance.
  • Vulnerability to raw material price volatility in polymer supply chains.

Investment Verdict & Assessment

Suitable For: Long-term investors with high risk appetite for SME equities.

Risk Level: High — SME liquidity constraints and flat grey market trends warrant caution.

Key Watch Point: Post-listing price stabilization and execution of expansion milestones.

Frequently Asked Questions

Should investors apply for Injecto Polymers IPO shares based on valuations?

Investors should evaluate their risk profile before committing capital to SME issues. While valuations align with industry peers, the moderate subscription level of 1.23x suggests cautious participation rather than aggressive demand.

What is the Grey Market Premium (GMP) and expected listing sentiment for Injecto Polymers?

The grey market premium for Injecto Polymers traded around ₹0 after the subscription window closed. This flat GMP points toward a muted or par listing debut on the BSE SME platform.

What are the primary balance sheet strengths and risk factors for Injecto Polymers?

Key strengths include dedicated capital allocation for manufacturing growth, while primary risks involve input cost fluctuations and limited secondary liquidity typical of SME public issues.

SEBI Compliance & Statutory Disclaimer

The information and analysis presented on IPO Bulletin (ipobulletin.com) are for informational and educational purposes only and do not constitute financial, investment, or legal advice. Securities market investments are subject to market risks; please read all offer documents (DRHP/RHP) thoroughly before committing capital. Grey Market Premium (GMP) figures are unofficial, unregulated street estimates. Always consult a SEBI-registered investment advisor before making financial decisions.

Sources cross-checked for this article: IPOWatch, Chittorgarh, Moneycontrol, BSE India filings, Screener.in